The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNanoco Regulatory News (NANO)

Share Price Information for Nanoco (NANO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 20.20
Bid: 19.82
Ask: 20.20
Change: 0.60 (3.09%)
Spread: 0.38 (1.917%)
Open: 19.42
High: 20.50
Low: 19.42
Prev. Close: 19.41
NANO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

PrimaryBid.com Offer

15 Jul 2020 17:20

RNS Number : 1337T
Nanoco Group PLC
15 July 2020
 

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014.

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO, OR TO ANY PERSON LOCATED OR RESIDENT IN, ANY JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS ANNOUNCEMENT.

THIS ANNOUNCEMENT AMOUNTS TO A FINANCIAL PROMOTION FOR THE PURPOSES OF SECTION 21 OF THE FINANCIAL SERVICES AND MARKETS ACT 2000 ("FSMA") AND HAS BEEN APPROVED BY PRIMARYBID LIMITED WHICH IS AUTHORISED AND REGULATED BY THE FINANCIAL CONDUCT AUTHORITY (FRN 779021)

 

15 July 2020

 

Nanoco Group plc

("Nanoco" or the "Company") (LON:NANO)

PrimaryBid.com Offer

 

Nanoco Group plc (LON:NANO), a world leader in the development and manufacture of cadmium-free quantum dots and other specific nanomaterials emanating from its technology platform, is pleased to announce an offer for subscription via PrimaryBid (the "PrimaryBid Offer") of new ordinary shares of 10p each in the Company ("New Ordinary Shares") at an issue price of 17.5 pence per New Ordinary Share (the "Issue Price"), being a discount of 2.8% per cent to the closing mid-price on 15 July 2020 as announced earlier on 15 July 2020 .

The PrimaryBid Offer is conditional on the new Ordinary Shares to be issued pursuant to the PrimaryBid Offer being admitted to listing on the Official List by the Financial Conduct Authority and to trading by the London Stock Exchange on its main market for listed securities ("Admission"). Admission is expected to be take place at 8.00 a.m. on 20 July 2020.

The net proceeds of the Fundraising will be used to extend the Company's cash runway at least to the end of calendar year 2021 while supporting its core IP assets and its business operations during the ongoing lawsuit against Samsung.

The Company's largest shareholder, Lombard Odier, has undertaken to subscribe for £2.14m of New Ordinary Shares on the same terms as those set out above, which subscription shall be subject to claw back depending on the amount of the other aggregate applications received from other investors under the PrimaryBid Offer. Lombard Odier will receive, conditional upon Admission (as defined below), a subscription commission equal to 3.0 per cent of the amount it subscribes . In the event that Admission does not occur, Lombard Odier will not receive any commission payment. .

Certain directors of the Company and/or persons closely associated with them have given written undertakings to the Company to subscribe for PrimaryBid Shares at the Issue Price with a total value of £61,000.

PrimaryBid Offer

The Company values its retail investor base and is therefore pleased to provide private and other investors the opportunity to participate in the PrimaryBid Offer by applying exclusively through the www.PrimaryBid.com platform and the PrimaryBid mobile app available on the Apple App Store and Google Play. PrimaryBid does not charge investors any commission for this service.

The PrimaryBid Offer, via the PrimaryBid.com platform, will be open to individual and institutional investors immediately following this announcement and will close at 9:00 p.m. on 15 July 2020. The PrimaryBid Offer may close early if it is oversubscribed.

Subscriptions under the PrimaryBid Offer will be considered by the Company on a "first come, first served" basis, subject to conditions (which are available to view on PrimaryBid.com).

The Company in consultation with PrimaryBid reserves the right to scale back any order at its discretion. The Company and PrimaryBid reserve the right to reject any application for subscription under the Offer without giving any reason for such rejection. It is not intended that the Director orders be subject to scale back.

No commission is charged to investors on applications to participate in the PrimaryBid Offer made through PrimaryBid. It is vital to note that once an application for New Ordinary Shares has been made and accepted via PrimaryBid, an application cannot be withdrawn.

For further information on PrimaryBid.com or the procedure for applications under the PrimaryBid Offer, visit www.PrimaryBid.com or call PrimaryBid.com on +44 20 3026 4750. 

The New Ordinary Shares will be issued free of all liens, charges and encumbrances and will, when issued and fully paid, rank pari passu in all respects with the Company's existing Ordinary Shares.

Nanoco Group PLC

Michael Edelman, CEO

Brian Tenner, COO & CFO

Caroline Watson, Investor Relations Manager

 

+44 (0) 161 603 7900

PrimaryBid Limited

James Deal / Kieran D'Silva

 

+ 44 (0) 203 026 4750

Further Details of the Offer

The Company highly values its retail investor base which has supported the Company alongside institutional investors over several years. Given the longstanding support of retail shareholders, the Company believes that it is appropriate to provide retail and other interested investors the opportunity to participate in the Offer. The Company is therefore making the Offer available exclusively through PrimaryBid.com.

The Offer is offered under the exemptions against the need for a prospectus allowed under the Prospectus Rules. As such, there is no need for publication of a prospectus pursuant to the Prospectus Rules, or for approval of the same by the Financial Conduct Authority in its capacity as the UK Listing Authority. The Offer is not being made into any Restricted Jurisdiction or any other jurisdiction where it would be unlawful to do so.

There is a minimum subscription of £100 per investor under the terms of the Offer which is open to existing shareholders and other investors subscribing via PrimaryBid.com. This allocation will be filled on a "first come first served" basis.

For further details please refer to the PrimaryBid.com website at www.PrimaryBid.com. The terms and conditions on which the Offer is made, including the procedure for application and payment for New Ordinary Shares, is available to all persons who register with PrimaryBid.com.

Investors should make their own investigations into the merits of an investment in the Company. Nothing in this announcement amounts to a recommendation to invest in the Company or amounts to investment, taxation or legal advice.

It should be noted that a subscription for New Ordinary Shares and investment in the Company carries a number of risks. Investors should consider the risk factors set out on PrimaryBid.com before making a decision to subscribe for New Ordinary Shares. Investors should take independent advice from a person experienced in advising on investment in securities such as the New Ordinary Shares if they are in any doubt. 

 

 

END

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
OFFBLGDRXBBDGGU
Date   Source Headline
25th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
24th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
23rd Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
22nd Apr 20244:06 pmRNSTR-1: Notification of Major Holdings
22nd Apr 20247:00 amRNSTransaction in Own Shares
19th Apr 20247:00 amRNSTransaction in Own Shares
18th Apr 20243:02 pmRNSExercise of Deferred Bonus Options
18th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
17th Apr 20241:56 pmRNSNotification of Major Holdings
17th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
16th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
15th Apr 20244:10 pmRNSDirector/PDMR Shareholding
15th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
11th Apr 20247:00 amRNSResult of Tender Offer
28th Mar 202412:52 pmRNSGeneral Meeting - Voting Results
27th Mar 20247:00 amRNSInterim Results
11th Mar 202412:47 pmRNSPosting of Circular
11th Mar 20247:00 amRNSProposed return of up to £33.0 million
8th Feb 20247:00 amRNSHalf Year Trading Update
7th Feb 202411:23 amRNSDirector Declaration
24th Jan 20247:00 amRNSReceipt of Final Litigation Proceeds
23rd Jan 20244:02 pmRNSNotification Of Transactions By PDMR
16th Jan 20243:40 pmRNSDirector/PDMR Shareholding
15th Jan 20244:35 pmRNSHolding(s) in Company
12th Jan 20249:45 amRNSJoint Development Agreement with European Customer
22nd Dec 20237:00 amRNSAppointment of Financial Adviser and Joint Broker
21st Dec 202312:00 pmRNSAppointments of Non-Executive Directors
12th Dec 20239:35 amRNSBlocklisting six-monthly return
7th Dec 20233:23 pmRNSResult of AGM
7th Dec 20237:00 amRNSAGM Statement & Trading Update
15th Nov 20237:00 amRNSFirst ever commercial production order
13th Nov 20234:28 pmRNS2023 Annual Report and Notice of AGM
7th Nov 20237:00 amRNSJoint Development Agreement with Asian Customer
2nd Nov 20232:18 pmRNSHolding(s) in Company
17th Oct 20237:00 amRNSUnaudited Preliminary Results
10th Oct 20237:00 amRNSNotice of Results
3rd Oct 20234:32 pmRNSForeign Currency Hedge of Litigation Settlement
14th Aug 20233:58 pmRNSResult of Meeting
8th Aug 20237:00 amRNSTrading Update
7th Aug 20237:00 amRNSGlass Lewis recommends to support Nanoco’s Board
2nd Aug 20237:00 amRNSHolding(s) in Company
2nd Aug 20237:00 amRNSISS recommendation to support Nanoco’s Board
1st Aug 20237:13 amRNSTotal Voting Rights
28th Jul 20235:23 pmRNSDirector/PDMR Shareholding
25th Jul 20232:55 pmRNSPublication of Shareholder Presentation
25th Jul 202312:52 pmRNSNanoco Group Plc
24th Jul 20237:00 amRNSHigh Court Confirmation of Capital Reduction
20th Jul 20237:00 amRNSNotification of Investor Presentation
18th Jul 20237:00 amRNSPosting of Circular and Notice of General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.